The roles of MASPIN expression and subcellular localization in non-small cell lung cancer.
Ontology highlight
ABSTRACT: Accumulating studies have confirmed that mammary serine protease inhibitor (MASPIN) plays an essential role in non-small cell lung cancer (NSCLC). However, results are still controversial or inconsistent. In the present study, we attempted to identify the clinical significance of MASPIN and its potential molecular roles in NSCLC. The correlation of MASPIN with prognosis and clinicopathological characteristics was assessed by meta-analysis. Additionally, the potential molecular mechanisms of MASPIN in NSCLC was also investigated through several online databases. A total of 2220 NSCLC patients from 12 high quality studies were included and the results indicated that up-regulated MASPIN nucleus and cytoplasm expression was associated with poor overall survival (OS) (hazard ratio (HR) = 1.43,
SUBMITTER: Wang XF
PROVIDER: S-EPMC7251327 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
ACCESS DATA